Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

The burden of invasive pneumococcal disease and the potential for reduction by immunisation.

Parsons HK, Dockrell DH.

Int J Antimicrob Agents. 2002 Feb;19(2):85-93. Review.

PMID:
11850160
[PubMed - indexed for MEDLINE]
2.

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M.

Lancet. 2003 Aug 2;362(9381):355-61.

PMID:
12907008
[PubMed - indexed for MEDLINE]
3.

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T; Hib and Pneumococcal Global Burden of Disease Study Team.

Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6. Review.

PMID:
19748398
[PubMed - indexed for MEDLINE]
4.

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.

Pediatrics. 2009 Jun;123(6):e1103-10. doi: 10.1542/peds.2008-3422.

PMID:
19482744
[PubMed - indexed for MEDLINE]
Free Article
5.

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

Evers SM, Ament AJ, Colombo GL, Konradsen HB, Reinert RR, Sauerland D, Wittrup-Jensen K, Loiseau C, Fedson DS.

Eur J Clin Microbiol Infect Dis. 2007 Aug;26(8):531-40.

PMID:
17570001
[PubMed - indexed for MEDLINE]
6.

Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.

Simberkoff MS.

Semin Respir Infect. 1993 Dec;8(4):294-9. Review.

PMID:
7938926
[PubMed - indexed for MEDLINE]
7.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.

Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Review.

PMID:
18343273
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of the pneumococcal vaccine in healthy younger adults.

Pepper PV, Owens DK.

Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S45-57.

PMID:
12369231
[PubMed - indexed for MEDLINE]
9.

Pneumococcal conjugate vaccine--a health priority.

Zar HJ, Madhi SA.

S Afr Med J. 2008 Jun;98(6):463-7.

PMID:
18683380
[PubMed - indexed for MEDLINE]
10.

Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia.

Paragi M, Kolman J, Kraigher A, Cizman M, Gubina M, Ribic H; Slovenian Meningitis Study Group.

Vaccine. 2003 Dec 1;21(32):4708-14.

PMID:
14585680
[PubMed - indexed for MEDLINE]
11.

Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE.

Pediatr Infect Dis J. 2005 Apr;24(4):320-3.

PMID:
15818291
[PubMed - indexed for MEDLINE]
12.

Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).

McIntosh ED, Conway P, Willingham J, Hollingsworth R, Lloyd A.

Vaccine. 2005 Feb 25;23(14):1739-45.

PMID:
15705480
[PubMed - indexed for MEDLINE]
13.

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Albrich WC, Baughman W, Schmotzer B, Farley MM.

Clin Infect Dis. 2007 Jun 15;44(12):1569-76. Epub 2007 May 8.

PMID:
17516400
[PubMed - indexed for MEDLINE]
Free Article
14.

Pneumococcal pneumonia including diagnosis and therapy of infection caused by penicillin-resistant strains.

Musher DM.

Infect Dis Clin North Am. 1991 Sep;5(3):509-21. Review.

PMID:
1955697
[PubMed - indexed for MEDLINE]
15.

Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.

Fedson DS.

Semin Respir Infect. 1993 Dec;8(4):285-93. Review.

PMID:
7938925
[PubMed - indexed for MEDLINE]
16.

Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.

Camou T, Palacio R, Di Fabio JL, Hortal M.

Vaccine. 2003 May 16;21(17-18):2093-6.

PMID:
12706699
[PubMed - indexed for MEDLINE]
17.

Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries.

Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, Jönsson B, Verhaegen J, Gaillat J, Christie P, Cifre AS, Vivas D, Loiseau C, Fedson DS.

Clin Infect Dis. 2000 Aug;31(2):444-50. Epub 2000 Sep 5.

PMID:
10987703
[PubMed - indexed for MEDLINE]
Free Article
18.

Pneumococcal infections and pneumococcal vaccine: an update.

Rytel MW.

Infect Control. 1982 Jul-Aug;3(4):295-8.

PMID:
6922092
[PubMed - indexed for MEDLINE]
19.

Streptococcus pneumoniae: does antimicrobial resistance matter?

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):210-38. doi: 10.1055/s-0029-1202939. Epub 2009 Mar 18. Review.

PMID:
19296420
[PubMed - indexed for MEDLINE]
20.

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine.

Aristegui J, Bernaola E, Pocheville I, García C, Arranz L, Durán G, Pérez L, Bastida M, Canduela C, Herranz Aguirre M, Garrote E, Fletcher MA, Pérez C.

Eur J Clin Microbiol Infect Dis. 2007 May;26(5):303-10.

PMID:
17457623
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk